RESUMEN
A common edible mushroom Lentinula edodes, is an important source of numerous biologically active substances, including polysaccharides, with immunomodulatory and antitumor properties. In the present work, the biological activity of the crude, homogenous (Se)-enriched fraction (named Se-Le-30), which has been isolated from L. edodes mycelium by a modified Chihara method towards human peripheral blood mononuclear cells (PBMCs) and peripheral granulocytes, was investigated. The Se-Le-30 fraction, an analog of lentinan, significantly inhibited the proliferation of human PBMCs stimulated with anti-CD3 antibodies or allostimulated, and down-regulated the production of tumor necrosis factor (TNF)-α by CD3+ T cells. Moreover, it was found that Se-Le-30 significantly reduced the cytotoxic activity of human natural killer (NK) cells. The results suggested the selective immunosuppressive activity of this fraction, which is non-typical for mushroom derived polysaccharides.
Asunto(s)
Polisacáridos Fúngicos/farmacología , Leucocitos Mononucleares/citología , Selenio/química , Hongos Shiitake/química , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo , Granulocitos/citología , Granulocitos/efectos de los fármacos , Granulocitos/inmunología , Humanos , Células Asesinas Naturales/metabolismo , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Micelio/química , Superóxidos/metabolismo , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Asparagus (Asparagus officinalis L.) is one of the widely consumed vegetables. To investigate the mechanism underlying the anti-allergic responses of asparagus, we extracted different fractions from asparagus and measured their inhibitory effects on ß-hexosaminidase release in RBL-2H3 cells in vitro and an atopic dermatitis NC/Nga mouse model in vivo. The lipid fractions from asparagus were extracted with 50% ethanol, separated using chloroform by liquid-liquid phase separation, and fractionated by solid-phase extraction. Among them, acetone fraction (rich in glycolipid) and MeOH fraction (rich in phospholipid) markedly inhibited ß-hexosaminidase release from RBL-2H3 cells. In NC/Nga mice treated with picryl chloride, atopic dermatitis was alleviated following exposure to the 50% EtOH extract, acetone fraction, and methanol fraction. The inhibitory effects of asparagus fractions in vivo were supported by the significant decrease in serum immunoglobulin E (IgE) levels. The phospholipid fractions showed significantly better inhibitory effects, and phosphatidic acid from this fraction showed the best inhibitory effect on ß-hexosaminidase release. In mice challenged with ovalbumin (OVA), oral administration of asparagus extract and its fractions decreased the OVA-specific IgE level and total IgE, indicating that these effects may be partly mediated through the downregulation of antigen-specific IgE production. Taken together, the present study shows for the first time that asparagus extract and its lipid fractions could potentially mitigate allergic reactions by decreasing degranulation in granulocytes. Our study provides useful information to develop nutraceuticals and functional foods fortified with asparagus.
Asunto(s)
Antialérgicos/administración & dosificación , Asparagus/química , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/inmunología , Fosfolípidos/administración & dosificación , Extractos Vegetales/administración & dosificación , Animales , Antialérgicos/química , Antialérgicos/aislamiento & purificación , Femenino , Granulocitos/efectos de los fármacos , Granulocitos/inmunología , Hexosaminidasas/inmunología , Humanos , Inmunoglobulina E/inmunología , Ratones Endogámicos BALB C , Fosfolípidos/química , Fosfolípidos/aislamiento & purificación , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificaciónRESUMEN
Asthma is a complex airways disease with a wide spectrum which ranges from eosinophilic (Th2 driven) to mixed granulocytic (Th2/Th17 driven) phenotypes. Mixed granulocytic asthma is a cause of concern as corticosteroids often fail to control this phenotype. Different kinases such as Brutons's tyrosine kinase (BTK) and IL-2 inducible T cell kinase (ITK) play a pivotal role in shaping allergic airway inflammation. Ibrutinib is primarily a BTK inhibitor, however it is reported to be an ITK inhibitor as well. In this study, we sought to determine the effect of Ibrutinib on Th1, Th17 and Th2 immune responses in a cockroach allergen extract (CE)-induced mixed granulocytic (eosinophilic and neutrophilic) mouse model in preventative mode. Ibrutinib attenuated neutrophilic inflammation at a much lower doses (25-75⯵g/mouse) in CE-induced mixed granulocytic asthma whereas Th2/Th17 immune responses remained unaffected at these doses. However, at a much higher dose, i.e. 250⯵g/mouse, Ibrutinib remarkably suppressed both Th17/Th2 and lymphocytic/neutrophilic/eosinophilic airway inflammation. At molecular level, Ibrutinib suppressed phosphorylation of BTK in neutrophils at lower doses and ITK in CD4â¯+â¯T cells at higher doses in CE-treated mice. Further, effects of Ibrutinib were compared with dexamethasone on CE-induced mixed granulocytic asthma in therapeutic mode. Ibrutinib was able to control granulocytic inflammation along with Th2/Th17 immune response in therapeutic mode whereas dexamethasone limited only Th2/eosinophilic inflammation. Thus, Ibrutinib has the potential to suppress both Th17/Th2 and neutrophilic/eosinophilic inflammation during mixed granulocytic asthma and therefore may be pursued as alternative therapeutic option in difficult-to-treat asthma which is resistant to corticosteroids.
Asunto(s)
Agammaglobulinemia Tirosina Quinasa/antagonistas & inhibidores , Antiasmáticos/farmacología , Asma/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Interleucina-2/antagonistas & inhibidores , Neutrófilos/efectos de los fármacos , Proteínas Tirosina Quinasas/metabolismo , Agammaglobulinemia Tirosina Quinasa/inmunología , Alérgenos/inmunología , Animales , Asma/inducido químicamente , Asma/inmunología , Asma/metabolismo , Cucarachas/inmunología , Citocinas/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Granulocitos/inmunología , Granulocitos/metabolismo , Inflamación/inmunología , Inflamación/metabolismo , Interleucina-2/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Neutrófilos/inmunología , Neutrófilos/metabolismo , Extractos Vegetales/inmunología , Proteínas Tirosina Quinasas/inmunología , Células Th17/efectos de los fármacos , Células Th17/inmunología , Células Th17/metabolismo , Células Th2/efectos de los fármacos , Células Th2/inmunología , Células Th2/metabolismoRESUMEN
Despite extensive investigation focused on both the molecular characteristics and the expression level of Toll-like receptors (TLRs) during the inflammatory response in vertebrates, few data are available in the literature on the role of these proteins in invertebrate's immune response. Here, we propose the medicinal leech as a valuable model to better elucidate the role of TLR4 and its related products, such as tumor necrosis factor (TNF-α), after activation of the leech peripheral immune system with the endogenous medicinal leech recombinant allograft inflammatory factor-1 (rHmAIF-1) or with an exogenous stimulus, such as lipopolysaccharide (LPS). Our results indicate that activated macrophages (HmAIF-1+) and granulocytes (CD11b+) express both TLR4 and its coreceptor CD14. Moreover, functional studies performed by injecting a cyanobacterium selective TLR4 antagonist CyP demonstrated that only the TLR4 pathway was blocked, while the immune response caused by lipoteichoic acid (LTA) treatment is not affected. These results are consistent with literature on vertebrates, indicating that TLR4 functions as a LPS receptor while the recognition of LTA may involve other pathways.
Asunto(s)
Modelos Animales de Enfermedad , Granulocitos/inmunología , Inflamación/inmunología , Sanguijuelas , Macrófagos/inmunología , Receptor Toll-Like 4 , Animales , Proteínas de Unión al Calcio/inmunología , Granulocitos/citología , Aplicación de Sanguijuelas , Receptores de Lipopolisacáridos/inmunología , Lipopolisacáridos/inmunología , Lipopolisacáridos/farmacología , Macrófagos/citología , Proteínas de Microfilamentos/inmunología , Ácidos Teicoicos/farmacología , Receptor Toll-Like 4/inmunología , Receptor Toll-Like 4/fisiología , Factor de Necrosis Tumoral alfa/inmunologíaRESUMEN
Gum arabic (GA) is a traditional herbal medicine from Acacia Senegal (L.) Willdenow trees, which consist of a complex mixture of polysaccharides and glycoproteins. It is used in daily applications for several diseases and is considered to protect against bacterial infections. The detailed mechanisms behind these observations are still unclear. In this study, we investigated the direct antibacterial activity of GA water and ethanol extracts against Staphylococcus (S.) aureus or Escherichia (E.) coli and the immunomodulating properties of those extracts on granulocytes as a first line of defense against bacteria. Firstly, the direct antimicrobial effect of GA was tested on three different S. aureus strains and two E. coli strains. The growth of bacteria was analyzed in the presence of different GA concentrations over time. GA water as well as ethanol extracts showed a significant growth inhibition in a concentration-dependent manner in the case of S. aureus Newman, S. aureus Rd5, and E. coli 25922, but not in the case of S. aureus USA300 and E. coli K1. Transmission electron microscopic analysis confirmed an antibacterial effect of GA on the bacteria. Secondly, the immunomodulatory effect of GA on the antimicrobial activity of bovine or human blood-derived granulocytes was evaluated. Interestingly, water and ethanol extracts enhanced antimicrobial activity of granulocytes by the induction of intracellular ROS production. In line with these data, GA increased the phagocytosis rate of E. coli. No effect was seen on neutrophil extracellular trap (NET) formation that mediates killing of extracellular bacteria such as S. aureus. In conclusion, we show that GA exhibits a direct antibacterial effect against some S. aureus and E. coli strains. Furthermore, GA boosts the antimicrobial activities of granulocytes and increases intracellular ROS production, which may lead to more phagocytosis and intracellular killing. These data might explain the described putative antimicrobial activity of GA used in traditional medicine.
Asunto(s)
Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Escherichia coli/inmunología , Granulocitos/efectos de los fármacos , Granulocitos/inmunología , Goma Arábiga/farmacología , Factores Inmunológicos/farmacología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/inmunología , Animales , Antibacterianos/química , Bovinos , Relación Dosis-Respuesta a Droga , Escherichia coli/ultraestructura , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/metabolismo , Infecciones por Escherichia coli/microbiología , Granulocitos/metabolismo , Goma Arábiga/química , Humanos , Factores Inmunológicos/química , Pruebas de Sensibilidad Microbiana , Polisacáridos Bacterianos/inmunología , Especies Reactivas de Oxígeno , Infecciones Estafilocócicas/inmunología , Infecciones Estafilocócicas/metabolismo , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/ultraestructuraRESUMEN
The experiments on C57Bl/6 mice with Lewis lung carcinoma showed that addition of Tussilago farfara L. polysaccharides to conventional cisplatin/paclitaxel polychemotherapy moderated neutropenia caused by antitumor therapy and increased its efficiency. The stimulating effect of polysaccharides on the granulopoietic lineage cells is comparable with that of recombinant CSF Neupogen.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Carcinoma Pulmonar de Lewis/tratamiento farmacológico , Cisplatino/farmacología , Paclitaxel/farmacología , Polisacáridos/farmacología , Tussilago/química , Animales , Antineoplásicos Fitogénicos/aislamiento & purificación , Carcinoma Pulmonar de Lewis/inmunología , Carcinoma Pulmonar de Lewis/patología , Femenino , Filgrastim/farmacología , Granulocitos/efectos de los fármacos , Granulocitos/inmunología , Granulocitos/patología , Fármacos Hematológicos/farmacología , Recuento de Leucocitos , Ratones , Ratones Endogámicos C57BL , Extractos Vegetales/química , Polisacáridos/aislamiento & purificación , Resultado del Tratamiento , Carga Tumoral/efectos de los fármacosRESUMEN
The use of antibiotics during pregnancy and lactation is associated with an increased risk of developmental disorders. One of the natural medicinal plants-Rhodiola kirilowii, widely used as an immunostimulant in adults-might be a good alternative to antibiotic treatment. The aim of present study was to assess whether daily oral administration of 20 mg/kg of Rhodiola kirilowii aqueous (RKW) or 50% hydroalcoholic (RKW-A) extracts affected hematological and immunological parameters of 6-week-old mouse progeny. There was no significant change in hematological parameters of blood with the exception of hemoglobin, which was significantly higher (about 4%) in RKW group. Offspring of mothers fed Rhodiola kirilowii extracts had increased percentage of granulocytes and decreased percentage of lymphocytes. These changes correlated with decreased percentage of CD3+/CD4+ T-cells (RKW and RKW-A), decrease of CD8+ cells, and increase percentage of NK cells in RKW group. In addition, both types of Rhodiola kirilowii extracts stimulated granulocyte phagocytosis and increased level of respiratory burst. In conclusion, the long-term supplementation of mouse mothers during pregnancy and lactation with RKW or RKW-A extracts affects the immune system of their progeny. These results should be taken into consideration before administration of Rhodiola kirilowii to pregnant and lactating women.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Granulocitos/inmunología , Células Asesinas Naturales/inmunología , Extractos Vegetales/uso terapéutico , Complicaciones del Embarazo/tratamiento farmacológico , Subgrupos de Linfocitos T/inmunología , Inmunidad Adaptativa , Animales , Femenino , Hemoglobinas/metabolismo , Inmunidad Innata , Inmunidad Materno-Adquirida , Lactancia/efectos de los fármacos , Masculino , Ratones , Fagocitosis , Embarazo , Estallido Respiratorio , Rhodiola/inmunologíaRESUMEN
Dipeptidyl peptidase I (DPPI), a lysosomal cysteine protease, required for activation of serine proteases of granulocytes including mast cells (MCs), neutrophils (NPs) and others, which were found in synovial tissue of patients with rheumatoid arthritis (RA). But, the role of DPPI associated with those cells in RA development is unclear. In this study, the collagen-induced-arthritis (CIA) rat-model was employed to investigate the expression and activity levels of DPPI and its association with RA progress. Primary granulocytes were freshly extracted from bone-marrows of normal or CIA rats, human mast cell line LAD-2 and primary neutrophils, human-recombinant-DPPI, DPPI-inhibitor Gly-Phe-CHN2 , LTB4, anti-IgE antibody, calcium ionophore were used to study the regulatory role of DPPI in cell activations. The increased DPPI activities in synovial fluids, serum, and bone-marrow homogenates of CIA rats associated with RA severities progress were observed after injections. MMP2/9 expressions in SFs and bone-marrow were in different patterns. Regular-Blood-Tests have shown the high leveled DPPI activities associated with granulocytes differentiations in-vivo in blood of CIA rats. In-vitro cell models, DPPI up-regulated the proliferation of primary bone-marrow granulocytes of normal rats, but inhibited that of CIA rats. DPPI up-regulated and Gly-Phe-CHN2 down-regulated MCs intracellular DPPI and chymase activities. Gly-Phe-CHN2 also inhibited the LTB4 -activated-NPs and NP-elastase activities. Following stimulation of calcium ionophore, the net-releases of DPPI and ß-hexosaminidase from MCs were increased over a time-course, while Gly-Phe-CHN2 down-regulated MCs and NPs activation. Our findings demonstrate the role of DPPI in regulating MCs and NPs activation, and modulating proteolysis in the process of RA.
Asunto(s)
Catepsina C/metabolismo , Granulocitos/enzimología , Animales , Anticuerpos Antiidiotipos , Artritis Experimental/enzimología , Artritis Experimental/inmunología , Artritis Experimental/metabolismo , Catepsina C/sangre , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Granulocitos/inmunología , Granulocitos/metabolismo , Masculino , Mastocitos/metabolismo , Neutrófilos/metabolismo , Ratas , Ratas Wistar , Líquido Sinovial/enzimología , Líquido Sinovial/inmunología , Líquido Sinovial/metabolismoRESUMEN
INTRODUCTION: Patients with inflammatory bowel diseases (IBD) require life-long medications, which even if effective have the potential to cause adverse effects as additional morbidity factors. In pediatric patients, drug therapy has more serious limitations, including impaired physical and mental development. A non-drug therapeutic option is believed to be depletion of elevated and activated granulocytes and monocytes known to release inflammatory cytokines, like the CD14+CD16+ monocyte phenotype known to release tumor necrosis factor-α. Areas covered: Granulomonocyteapheresis (GMA) with an Adacolumn as a treatment option for IBD patients has been applied for the past 15 years. This article reviews the argument that GMA is a relevant and effective non-pharmacologic intervention in pediatric IBD setting. Expert commentary: GMA with an Adacolumn has shown promise in adult, pediatric, and adolescent patients with active IBD. There is evidence of post-GMA immunomodulation in terms of increased regulatory T-cell and B-cell activities. Additionally, patients who respond to GMA may attain a favorable long-term clinical course by avoiding pharmacologicals during an early phase of their active IBD. GMA has a good safety profile, especially in difficult-to-treat and pediatric settings. An additional trial is warranted to assess the efficacy of GMA in the early phase of pediatric IBD to optimize patient selection.
Asunto(s)
Colitis Ulcerosa/terapia , Enfermedad de Crohn/terapia , Granulocitos/inmunología , Leucaféresis/métodos , Monocitos/inmunología , Adolescente , Edad de Inicio , Antiinflamatorios/uso terapéutico , Niño , Preescolar , Colitis Ulcerosa/diagnóstico , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/inmunología , Fármacos Gastrointestinales/uso terapéutico , Humanos , Leucaféresis/instrumentación , Resultado del TratamientoRESUMEN
Since asthma is a multifactorial disease where treatment sometimes is not effective, new therapies that improve the respiratory discomfort of patients are of great importance. Phototherapy as Light-emitting diode (LED) has emerged as a treatment that presents good results for diseases that are characterized by inflammation. Thus, our objective was to investigate the effects of LED on lung inflammation, by an evaluation of lung cell infiltration, mucus secretion, oedema, and the production of cytokines. Male Balb/c mice were or not sensitized and challenged with ovalbumin (OVA) and treated or not with LED therapy (1â h and 4â h after each OVA challenge). Twenty-four hours after the last OVA challenge, analyzes were performed. Our results showed that LED treatment in asthmatic mice reduced the lung cell infiltration, the mucus production, the oedema, and the tracheal's contractile response. It also increased the IL-10 and the IFN-gamma levels. The effects of LED treatment on lung inflammation may be modulated by IL-10, IFN-gamma, and by mast cells. This study may provide important information about the effects of LED, and in addition, it may open the possibility of a new approach for the treatment of asthma.
Asunto(s)
Asma/inducido químicamente , Asma/complicaciones , Ovalbúmina/efectos adversos , Fototerapia/instrumentación , Neumonía/complicaciones , Neumonía/terapia , Animales , Líquido del Lavado Bronquioalveolar , Recuento de Células , Citocinas/metabolismo , Modelos Animales de Enfermedad , Granulocitos/inmunología , Granulocitos/efectos de la radiación , Linfocitos/inmunología , Linfocitos/efectos de la radiación , Macrófagos/inmunología , Macrófagos/efectos de la radiación , Masculino , Mastocitos/metabolismo , Mastocitos/efectos de la radiación , Ratones , Ratones Endogámicos BALB C , Contracción Muscular/efectos de la radiación , Neumonía/inmunología , Neumonía/fisiopatología , Tráquea/fisiopatología , Tráquea/efectos de la radiaciónRESUMEN
The aim of this research was to evaluate the influence of maternal cells from colostrum on the development and function of the innate immune response in Holstein calves. Calves were divided into 2 groups: COL+ (n=10) received fresh colostrum; and COL- (n=10) which received frozen colostrum containing no viable cells. The calves were assessed before colostrum intake (D0), 48h of age (D2), and weekly from D7 up to D28. Blood samples were collected for analysis of the distribution of leukocytes, cellular phenotype and in vitro granulocyte function. COL+ calves tended to have a high number of neutrophils on D7 (p=0.073). COL- calves took up significantly more Escherichia coli (measured as MFI) on D7 (p=0.034). Endogenous production of radicals (as percentage of cells) tended to be higher in COL- calves on D14 (p=0.061). The intensity of endogenous reactive oxygen species (ROS) produced by granulocytes tended to be higher in COL+ calves on D21 (p=0.094). Overall, ROS production (percent of cells, and MFI) induced by Staphylococcus aureus and Escherichia coli were higher in COL+ calves than COL- calves. It was our observation that COL+ calves developed an innate immune response more quickly and efficiently after natural exposure to pathogens after birth. In contrast, COL- calves mounted an innate response more slowly that yielded a persistent inflammatory response after natural exposure to these bacteria agents. This research provides evidence of an advantage to the calf of receiving fresh colostrum on the development and function of the innate immune system.
Asunto(s)
Alimentación Animal/análisis , Enfermedades de los Bovinos/inmunología , Granulocitos/inmunología , Inmunidad Innata , Inmunidad Materno-Adquirida , Animales , Animales Recién Nacidos , Bovinos , Enfermedades de los Bovinos/microbiología , Calostro , Dieta/veterinaria , Escherichia coli/fisiología , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/veterinaria , Femenino , Congelación , Infecciones Estafilocócicas/inmunología , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/veterinaria , Staphylococcus aureus/fisiologíaRESUMEN
One of the key immunological characteristics of active visceral leishmaniasis (VL) is a profound immunosuppression and impaired production of Interferon-γ (IFN-γ). However, recent studies from Bihar in India showed using a whole blood assay, that whole blood cells have maintained the capacity to produce IFN-γ. Here we tested the hypothesis that a population of low-density granulocytes (LDG) might contribute to T cell responses hyporesponsiveness via the release of arginase. Our results show that this population is affected by the anticoagulant used to collect blood: the frequency of LDGs is significantly lower when the blood is collected with heparin as compared to EDTA; however, the anticoagulant does not impact on the levels of arginase released. Next, we assessed the capacity of whole blood cells from patients with active VL to produce IFN-γ and IL-10 in response to antigen-specific and polyclonal activation. Our results show that whole blood cells produce low or levels below detection limit of IFN-γ and IL-10, however, after successful treatment of VL patients, these cells gradually regain their capacity to produce IFN-γ, but not IL-10, in response to activation. These results suggest that in contrast to VL patients from Bihar, India, whole blood cells from VL patients from Gondar, Ethiopia, have lost their ability to produce IFN-γ during active VL and that active disease is not associated with sustained levels of IL-10 production following stimulation.
Asunto(s)
Antígenos de Protozoos/inmunología , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Leishmaniasis Visceral/tratamiento farmacológico , Leishmaniasis Visceral/patología , Linfocitos T/inmunología , Adolescente , Adulto , Arginasa/metabolismo , Estudios Transversales , Etiopía , Granulocitos/inmunología , Humanos , India , Masculino , Linfocitos T/efectos de los fármacos , Resultado del Tratamiento , Adulto JovenRESUMEN
OBJECTIVE: This study was conducted to evaluate the effect of the synthetic water-soluble phenolic antioxidant TS-13 (sodium 3-(4'-methoxyphenyl)propyl thiosulfonate), an inducer of the redox-dependent Keap1/Nrf2/ARE signaling system, in experimental models of acute and chronic inflammation. METHODS: Acute local inflammation was induced by intraplantar carrageenan injection into rat hind paws, and acute systemic inflammation was modeled by intravenous zymosan injection (in rats) or LPS-induced endotoxic shock (in mice). Chronic inflammation was investigated in rat models of air pouch and collagen-induced arthritis. The effects of TS-13 treatment were estimated by changes in the intensity of inflammation (paw edema, liver infiltration, animal survival, exudation, and clinical score of arthritis) and by the effects on reactive oxygen species (ROS) generation by leukocytes from peripheral blood and inflammatory exudates. RESULTS: We found the significant increase in expression of mRNA, content of protein and activity of a well-characterized Nrf2 target enzyme glutathione S-transferase P1, as well as nuclear extract protein binding to the ARE consensus sequence in liver of mice fed with diet containing TS-13. TS-13 markedly attenuated carrageenan-induced paw edema, reduced blood granulocyte number and volume density of liver infiltrates in the systemic zymosan-induced inflammation model, and increased mice survival after lipopolysaccharide-induced septic shock. However, TS-13 administration did not influence cell and protein exudation into air pouches and suppressed clinical manifestation of collagen-induced polyarthritis only at early stages. Nevertheless, TS-13 inhibited the generation of ROS by leukocytes in all inflammation models. CONCLUSION: The data suggest that the anti-inflammatory effects of Keap1/Nrf2/ARE system are more prominent against acute innate-mediated inflammation than chronic immune inflammation. This narrows the potential therapeutic efficacy of ARE inducers in inflammation treatment.
Asunto(s)
Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Edema/tratamiento farmacológico , Choque Séptico/tratamiento farmacológico , Ácidos Tiosulfónicos/uso terapéutico , Enfermedad Aguda , Animales , Antiinflamatorios/química , Antiinflamatorios/farmacología , Elementos de Respuesta Antioxidante/inmunología , Antioxidantes/química , Antioxidantes/farmacología , Artritis Experimental/inmunología , Artritis Experimental/patología , Carragenina , Enfermedad Crónica , Edema/inducido químicamente , Edema/patología , Pie/patología , Gutatión-S-Transferasa pi/genética , Gutatión-S-Transferasa pi/metabolismo , Granulocitos/inmunología , Péptidos y Proteínas de Señalización Intracelular/inmunología , Proteína 1 Asociada A ECH Tipo Kelch , Recuento de Leucocitos , Lipopolisacáridos , Masculino , Ratones Endogámicos BALB C , Factor 2 Relacionado con NF-E2/inmunología , ARN Mensajero/metabolismo , Ratas Wistar , Especies Reactivas de Oxígeno/inmunología , Choque Séptico/inducido químicamente , Solubilidad , Ácidos Tiosulfónicos/química , Ácidos Tiosulfónicos/farmacología , Agua/química , ZimosanRESUMEN
We compared hemostimulating effects of glyciram, pantohematogen, granulocytic CSF, and D-glucuronic acid preparation on the granulocytic lineage hemopoiesis suppressed by cyclophosphamide or 5-fluorouracil. The effects hemostimulators against the background of 5-fluorouracil treatment were less pronounced that during cyclophosphamide treatment.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Factores Biológicos/farmacología , Ácido Glucurónico/farmacología , Ácido Glicirretínico/farmacología , Factor Estimulante de Colonias de Granulocitos/farmacología , Granulocitos/efectos de los fármacos , Hematopoyesis/efectos de los fármacos , Administración Oral , Animales , Ciclofosfamida/farmacología , Fluorouracilo/farmacología , Granulocitos/citología , Granulocitos/inmunología , Hematopoyesis/inmunología , Inmunosupresores/farmacología , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos CBARESUMEN
Chronic low-grade inflammation in adipose tissue has been recognized as a key step in the development of obesity-associated complications. In obesity, the accumulation of infiltrating macrophages in adipose tissue and their phenotypic switch to M1-type dysregulate inflammatory adipokine production leading to obesity-linked insulin resistance. Resolvins are potent anti-inflammatory and pro-resolving mediators endogenously generated from omega-3 fatty acids that act as "stop-signals" of the inflammatory response promoting the resolution of inflammation. Recently, a deficit in the production of these endogenous anti-inflammatory signals has been demonstrated in obese adipose tissue. The restoration of their levels by either exogenous administration of these mediators or feeding omega-3-enriched diets, improves the inflammatory status of adipose tissue and ameliorates metabolic dysfunction. Here, we review the current knowledge on the role of these endogenous autacoids in the resolution of adipose tissue inflammation with special emphasis on their functional actions on macrophages.
Asunto(s)
Tejido Adiposo Blanco/patología , Ácidos Grasos Omega-3/fisiología , Obesidad/patología , Adipocitos/inmunología , Adipocitos/metabolismo , Tejido Adiposo Blanco/inmunología , Animales , Granulocitos/inmunología , Granulocitos/metabolismo , Humanos , Inflamación , Linfocitos/inmunología , Linfocitos/metabolismo , Macrófagos/inmunología , Macrófagos/metabolismo , Mastocitos/inmunología , Mastocitos/metabolismo , Obesidad/inmunologíaRESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: The decoction of the roots of Hemidesmus indicus is widely used in the Indian traditional medicine for the treatment of blood diseases, dyspepsia, loss of taste, dyspnea, cough, poison, menorrhagia, fever, and diarrhea. Poly-herbal preparations containing Hemidesmus are often used by traditional medical practitioners for the treatment of cancer. The aim of this study was to investigate the cytodifferentiative, cytostatic and cytotoxic potential of a decoction of Hemidesmus indicus's roots (0.31-3 mg/mL) on a human promyelocytic leukemia cell line (HL-60). MATERIALS AND METHODS: The decoction of Hemidesmus indicus was characterized by HPLC to quantify its main phytomarkers. Induction of apoptosis, cell-cycle analysis, levels of specific membrane differentiation markers were evaluated by flow cytometry. The analysis of cell differentiation by nitroblue tetrazolium (NBT) reducing activity, adherence to the plastic substrate, α-napthyl acetate esterase activity and morphological analysis was performed through light microscopy (LM) and transmission electron microscopy (TEM). RESULTS: Starting from the concentration of 0.31 mg/ml, Hemidesmus indicus induced cytotoxicity and altered cell-cycle progression, through a block in the G0/G1 phase. The decoction caused differentiation of HL-60 cells as shown by NBT reducing activity, adherence to the plastic substrate, α-naphtyl acetate esterase activity, and increasing expression of CD14 and CD15. The morphological analysis by LM and TEM clearly showed the presence of granulocytes and macrophages after Hemidesmus indicus treatment. CONCLUSIONS: The cytodifferentiating, cytotoxic and cytostatic activities of Hemidesmus indicus offers a scientific basis for its use in traditional medicine. Its potent antileukemic activity provides a pre-clinical evidence for its traditional use in anticancer pharmacology. Further experiments are worthwhile to determine the in vivo anticancer potential of this plant decoction and its components.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Hemidesmus , Leucemia Promielocítica Aguda/patología , Preparaciones de Plantas/farmacología , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/aislamiento & purificación , Adhesión Celular/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Citometría de Flujo , Fucosiltransferasas/metabolismo , Granulocitos/efectos de los fármacos , Granulocitos/inmunología , Células HL-60 , Hemidesmus/química , Humanos , Leucemia Promielocítica Aguda/inmunología , Antígeno Lewis X/metabolismo , Receptores de Lipopolisacáridos/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Microscopía Electrónica de Transmisión , Fitoterapia , Preparaciones de Plantas/química , Preparaciones de Plantas/aislamiento & purificación , Raíces de Plantas , Plantas Medicinales , Factores de TiempoRESUMEN
BACKGROUND & AIMS: It remains unclear whether impaired host defenses contribute to the increased risk for infectious complications seen in patients on home parenteral nutrition (HPN). The aim of this study was to compare the innate immune function of patients on olive oil-based HPN with that of healthy controls. METHODS: Innate immune functions and (anti-)oxidant balance were studied in 20 patients on olive oil-based HPN without an active underlying immune-mediated disease (Clinoleic(®), ≥ 6 months; >3 times/week), and 21 age- and sex-matched healthy controls. RESULTS: Neutrophils of patients and controls had a similar capacity to eliminate Streptococcus pneumoniae. Also, levels of activation markers (CD66b, CD11b, CD62L) in granulocytes and monocytes, phorbol ester- and zymosan-induced neutrophil oxygen radical production were not different between patients and controls. No differences in (anti-)oxidant status were found, except for higher concentrations of oxidized glutathione and lower plasma selenium and vitamin C in patients compared to controls. CONCLUSION: Compromised innate immune function does not seem to explain the increased risk for infectious complications in HPN patients using olive oil-based lipid emulsions.
Asunto(s)
Inmunidad Innata , Nutrición Parenteral en el Domicilio , Aceites de Plantas/administración & dosificación , Aceite de Soja/administración & dosificación , Adulto , Antígenos CD/metabolismo , Antioxidantes/metabolismo , Ácido Ascórbico/sangre , Biomarcadores/sangre , Antígeno CD11b/metabolismo , Moléculas de Adhesión Celular/metabolismo , Femenino , Proteínas Ligadas a GPI/metabolismo , Disulfuro de Glutatión/sangre , Granulocitos/inmunología , Humanos , Selectina L/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Persona de Mediana Edad , Monocitos/inmunología , Neutrófilos/inmunología , Aceite de Oliva , Factores de Riesgo , Selenio/sangre , Streptococcus pneumoniaeRESUMEN
Bovine neonatal pancytopenia (BNP) is mainly characterized by multiple haemorrhages, thrombocytopenia and leukocytopenia as a result of bone marrow depletion. BNP can be induced in healthy calves through application of colostrum from BNP donors, proofing that BNP is mediated to maternal alloantibodies. Alloantibody binding to bovine blood cells is present in sera and colostra of BNP donors and is probably initialized by vaccination with a certain BVD vaccine. To understand etiology and pathomechanisms of BNP, we closely characterized disease inducing antibodies regarding immunoglobulin subclass and binding specificities to peripheral blood derived leukocytes and platelets. By exact phenotyping the targeted blood cell subsets, including platelets for the first time, we investigated that BNP alloantibodies are exclusively of IgG1 subclass. Interestingly, IgG1 of BNP colostra bound to 70% leukocytes and 100% platelets irrespective of different bovine breeds and cellular maturity of all specimens tested. Furthermore, staining pattern on platelets as well as leukocyte subsets by BNP-IgG1 alloantibody exposed 100% reactivity to platelets, granulocytes and monocytes. Interestingly, the main part of T-helper cells was not bound by colostral alloantibodies. Our results point to a crucial role of IgG1 antibodies in BNP and to a target antigen that is expressed by all cells of myeloid lineage, but only partially by the lymphoid lineage.
Asunto(s)
Plaquetas/inmunología , Enfermedades de los Bovinos/inmunología , Calostro/inmunología , Granulocitos/inmunología , Inmunoglobulina G/inmunología , Monocitos/inmunología , Pancitopenia/veterinaria , Animales , Animales Recién Nacidos , Especificidad de Anticuerpos , Plaquetas/citología , Bovinos , Diferenciación Celular , Granulocitos/citología , Antígenos de Histocompatibilidad Clase I/inmunología , Inmunofenotipificación , Isoanticuerpos/inmunología , Monocitos/citología , Pancitopenia/inmunologíaRESUMEN
BACKGROUND: Alteration in the proliferation capacity of leukocytes and in the level of some cytokines, such as TNF-α, IL-4 and IL-8 have been suggested to associate with Diabetes mellitus in alloxan-induced diabetic rats given the potential immunomodulatory effects of black seeds and garlic. AIM OF THE WORK: The aim of this study was to test the effects of these agents on the immune cells in alloxan-induced diabetic rats. METHODS: To this end, Diabetes was induced in albino rats by a single intraperitoneal injection of alloxan monohydrate (120mg/kg of body weight). Diabetic rats were then fed normal diet or diet with black seeds or garlic for 28 days. RESULTS: The results showed significant increase in the numbers of monocytes and granulocytes, but with significant decreases in lymphocyte proliferation and the TNF-α, interleukin (IL)-4 and IL-8 levels in the diabetic group. Treatment of diabetic rats with black seeds or garlic induced significant amelioration in the numbers of monocytes and granulocytes, with significant increase in lymphocytes numbers and the TNF-α, IL-4 and IL-8 levels. CONCLUSIONS: These results indicate the potential beneficial effects of black seeds and garlic as adjuvant treatment during treatment of Diabetes.
Asunto(s)
Citocinas/metabolismo , Diabetes Mellitus Experimental/terapia , Ajo/inmunología , Granulocitos/inmunología , Inmunomodulación , Monocitos/inmunología , Nigella sativa/inmunología , Animales , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Diabetes Mellitus Experimental/inmunología , Humanos , Recuento de Leucocitos , Linfocitos/inmunología , Masculino , Extractos Vegetales/administración & dosificación , Ratas , Ratas Endogámicas , Semillas/inmunologíaRESUMEN
Human peripheral blood mononuclear cells (PBMC) are routinely used in vitro to detect cytokine secretion as part of preclinical screens to delineate agonistic and antagonistic action of therapeutic monoclonal antibodies (mAbs). Preclinical value of standard human PBMC assays to detect cytokine release syndrome (CRS) has been questioned, as they did not predict the "cytokine storm" that occurred when healthy human volunteers were given a CD28-specific super-agonist mAb, TGN1412. In this article, we describe a three-dimensional biomimetic vascular test-bed that can be used as a more physiologically relevant assay for testing therapeutic Abs. For developing such a system, we used TGN1412 as a model mAb. We tested soluble TGN1412 on various combinations of human blood components in a module containing endothelial cells grown on a collagen scaffold and measured cytokine release using multiplex array. Our system, consisting of whole leukocytes, endothelial cells, and 100% autologous platelet-poor plasma (PPP) consistently produced proinflammatory cytokines in response to soluble TGN1412. In addition, other mAb therapeutics known to induce CRS or first infusion reactions, such as OKT3, Campath-1H, or Herceptin, generated cytokine profiles in our model system consistent with their in vivo responses. As a negative control we tested the non-CRS mAbs Avastin and Remicade and found little difference between these mAbs and the placebo control. Our data indicate that this novel assay may have preclinical value for predicting the potential of CRS for mAb therapeutics.